The comorbidity of epilepsy and depression: diagnosis and treatment

References

• Alsaadi T, El Hammasi K, Shahrour TM, et al. Depression and anxiety among patients with epilepsy and multiple sclerosis: UAE comparative study. Behav Neurol. 2015;2015:196373.
   PubMed Web of Science ®Google Scholar
• Garcia ME, Garcia-Morales I, Gil-Nagel A. Prevalence of depressive symptoms and their impact on quality of life in patients with drug-resistant focal epilepsy (IMDYVA study). Epilepsy Res. 2015 Feb;110:157–165.
   PubMed Web of Science ®Google Scholar
• Andrade-Machado R, Ochoa-Urrea M, Garcia-Espinosa A, et al. Suicidal risk, affective dysphoric disorders, and quality-of-life perception in patients with focal refractory epilepsy. Epilepsy Behav. 2015;45:254–260.
   PubMed Web of Science ®Google Scholar
• Andrade-Machado R, Benjumea-Cuartas V, Santos-Santos A, et al. Mortality in patients with refractory temporal lobe epilepsy at a tertiary center in Cuba. Epilepsy Behav. 2015 Nov 11;53:154–160.
   PubMed Web of Science ®Google Scholar
• Seo JG, Lee JJ, Cho YW, et al. Suicidality and its risk factors in Korean people with epilepsy: a MEPSY study. J Clin Neurol. 2015;11:32–41.
   PubMed Web of Science ®Google Scholar
• Lewis AJ. Melancholia: a historical review. J Ment Sci. 1934;80:1–42.
   Google Scholar
• Kraepelin E. Psychiatrie. Leipzig: Johann Ambrosius Barth; 1923.
   Google Scholar
• Bleuler E. Lehrbuch der Psychiatrie. Berlin: Springer; 1949.
   Google Scholar
• Barraclough B. Suicide and epilepsy. In: Reynolds EH, Trimble MR, editors. Epilepsy and psychiatry. New York: Churchill Livingstone Inc; 1981. p. 72–76.
   Google Scholar
• Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5:399–405.
   PubMed Web of Science ®Google Scholar
• Mula M, Sander JW. Suicide and epilepsy: do antiepileptic drugs increase the risk? Expert Opin Drug Saf. 2015 Apr;14:553–558.
   PubMed Web of Science ®Google Scholar
• Doucet GE, Skidmore C, Sharan AD, et al. Functional connectivity abnormalities vary by amygdala subdivision and are associated with psychiatric symptoms in unilateral temporal epilepsy. Brain Cogn. 2013;83:171–182.
   PubMed Web of Science ®Google Scholar
• Tosun A, Gokcen S, Ozbaran B, et al. The effect of depression on academic achievement in children with epilepsy. Epilepsy Behav. 2008;13:494–498.
   PubMed Web of Science ®Google Scholar
• Bosak M, Dudek D, Siwek M, et al. Subtypes of interictal depressive disorders according to ICD-10 in patients with epilepsy. Neurol Neurochir Pol. 2015;49:90–94.
   PubMed Web of Science ®Google Scholar
• Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006 Jan;59(1):35–41.
   PubMed Web of Science ®Google Scholar
• Adelöw C, Andersson T, Ahlbom A, et al. Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology. 2012 Feb;78(6):396–401.
   PubMed Web of Science ®Google Scholar
• Xie W, Cai L, Yu Y, et al. Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuroinflammation. 2014;11:41.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Barr WB, Vickrey BG, et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology. 2005 Dec 13;65:1744–1749.
   PubMed Web of Science ®Google Scholar
• Vujisić S, Vodopic S, Radulovic L, et al. Psychiatric comorbidities among patients with epilepsy in Montenegro. Acta Clin Croat. 2014;53:411–416.
   PubMed Web of Science ®Google Scholar
• Perini G, Mendius R. Depression and anxiety in complex partial seizures. J Nerv Ment Dis. 1984 May;172:287–290.
   PubMed Web of Science ®Google Scholar
• Swinkels WA, van Emde Boas W, Kuyk J, et al. Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE. Epilepsia. 2006;47:2092–2103.
   PubMed Web of Science ®Google Scholar
• Peng WF, Ding J, Li X, et al. Clinical risk factors for depressive symptoms in patients with epilepsy. Acta Neurol Scand. 2014;129:343–349.
   PubMed Web of Science ®Google Scholar
• Zis P, Yfanti P, Siatouni A, et al. Determinants of depression among patients with epilepsy in Athens, Greece. Epilepsy Behav. 2014;33:106–109.
   PubMed Web of Science ®Google Scholar
• Pereira A, Valente KD. Severity of depressive symptomatology and functional impairment in children and adolescents with temporal lobe epilepsy. Seizure. 2013 Nov;22:708–712.
   PubMed Web of Science ®Google Scholar
• Andersohn F, Schade R, Willich SN, et al. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 2010 Jul 27;75:335–340.
   PubMed Web of Science ®Google Scholar
• Machado RA, Espinosa AG, Melendrez D, et al. Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy. Seizure. 2011;20:280–284.
   PubMed Web of Science ®Google Scholar
• Brent DA, Crumrine PK, Varma R, et al. Phenobarbital treatment and major depressive disorder in children with epilepsy: a naturalistic follow-up. Pediatrics. 1990;85:1086–1091.
   PubMed Web of Science ®Google Scholar
• Leppik IE. Tiagabine: the safety landscape. Epilepsia. 1995;36(Suppl 6):S10–s13.
   PubMed Web of Science ®Google Scholar
• Andrew T, Milinis K, Baker G, et al. Self reported adverse effects of mono and polytherapy for epilepsy. Seizure. 2012;21:610–613.
   PubMed Web of Science ®Google Scholar
• Kui C, Yingfu P, Chenling X, et al. What are the predictors of major depression in adult patients with epilepsy? Epileptic Disord. 2014;16:74–79.
   PubMed Web of Science ®Google Scholar
• Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007 Jul;75(2–3):192–196.
   PubMed Web of Science ®Google Scholar
• Levinson DF, Devinsky O. Psychiatric adverse events during vigabatrin therapy. Neurology. 1999 Oct 22;53:1503–1511.
   PubMed Web of Science ®Google Scholar
• Ring HA, Crellin R, Kirker S, et al. Vigabatrin and depression. J Neurol Neurosurg Psychiatry. 1993;56:925–928.
   PubMed Web of Science ®Google Scholar
• Thomas L, Trimble M, Schmitz B, et al. Vigabatrin and behaviour disorders: a retrospective survey. Epilepsy Res. 1996;25:21–27.
   PubMed Web of Science ®Google Scholar
• Poston S, Dickson M, Johnsrud M, et al. Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosing. Clin Ther. 2007;29:504–518.
   PubMed Web of Science ®Google Scholar
• Fritz N, Glogau S, Hoffmann J, et al. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav. 2005;6:373–381.
   PubMed Web of Science ®Google Scholar
• Mula M, Trimble MR, Lhatoo SD, et al. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia. 2003;44:659–663.
   PubMed Web of Science ®Google Scholar
• Kellett MW, Smith DF, Stockton PA, et al. Topiramate in clinical practice: first year’s postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry. 1999;66:759–763.
   PubMed Web of Science ®Google Scholar
• Mula M, Trimble MR, Sander JW. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia. 2003 Dec;44:1573–1577.
   PubMed Web of Science ®Google Scholar
• Mula M, Hesdorffer DC, Trimble M, et al. The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia. 2009;50:1072–1076.
   PubMed Web of Science ®Google Scholar
• Delanty N, Jones J, Tonner F. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. Epilepsia. 2012 Jan;53:111–119.
   PubMed Web of Science ®Google Scholar
• Mula M, Trimble MR, Yuen A, et al. Psychiatric adverse events during levetiracetam therapy. Neurology. 2003 Sep 9;61:704–706.
   PubMed Web of Science ®Google Scholar
• Vande Griend JP, Linnebur SA, Bainbridge JL. Probable levetiracetam-associated depression in the elderly: two case reports. Am J Geriatr Pharmacother. 2009 Oct;7:281–284.
   PubMedGoogle Scholar
• Tamarelle C, Pandit F, Mazarati A, et al. Levetiracetam-induced depression in a 5-year-old child with partial epilepsy. Seizure. 2009;18:235–236.
   PubMed Web of Science ®Google Scholar
• Kaufman KR, Bisen V, Zimmerman A, et al. Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior. Epilepsy Behav Case Rep. 2013;1:110–112.
   PubMedGoogle Scholar
• Wrench JM, Rayner G, Wilson SJ. Profiling the evolution of depression after epilepsy surgery. Epilepsia. 2011 May;52:900–908.
   PubMed Web of Science ®Google Scholar
• Barbieri V, Cardinale F, Gozzo F, et al. Risk factors for postoperative depression: A retrospective analysis of 248 subjects operated on for drug-resistant epilepsy. Epilepsia. 2015;56:e149–55.
   PubMed Web of Science ®Google Scholar
• Wrench J, Wilson SJ, Bladin PF. Mood disturbance before and after seizure surgery: a comparison of temporal and extratemporal resections. Epilepsia. 2004 May;45(5):534–543.
   PubMed Web of Science ®Google Scholar
• Jobst BC. Epilepsy surgery and postoperative depression: charting difficult territory. Epilepsy Curr. 2012 Jan;12(1):37–39.
   PubMed Web of Science ®Google Scholar
• Wrench JM, Wilson SJ, O’Shea MF, et al. Characterising de novo depression after epilepsy surgery. Epilepsy Res. 2009;83:81–88.
   PubMed Web of Science ®Google Scholar
• Paparrigopoulos T, Ferentinos P, Brierley B, et al. Relationship between post-operative depression/anxiety and hippocampal/amygdala volumes in temporal lobectomy for epilepsy. Epilepsy Res. 2008;81:30–35.
   PubMed Web of Science ®Google Scholar
• Barbieri V, Cardinale F, Luoni A, et al. Risk factors for postoperative depression in 150 subjects treated for drug-resistant focal epilepsy. Epidemiol Psychiatr Sci. 2011;20:99–105.
   PubMed Web of Science ®Google Scholar
• Ipekdal HI, Karadas O, Erdogan E, et al. Spectrum of surgical complications of temporal lobe epilepsy surgery: a single - center study. Turk Neurosurg. 2011;21:147–151.
   PubMed Web of Science ®Google Scholar
• Reisinger EL, DiIorio C. Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months. Epilepsy Behav. 2009 Jun;15:196–201.
   PubMed Web of Science ®Google Scholar
• Fuller-Thomson E, Brennenstuhl S. The association between depression and epilepsy in a nationally representative sample. Epilepsia. 2009 May;50:1051–1058.
   PubMed Web of Science ®Google Scholar
• Bjork MH, Veiby G, Reiter SC, et al. Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis. Epilepsia. 2015;56:28–39.
   PubMed Web of Science ®Google Scholar
• Bifftu BB, Dachew BA, Tiruneh BT, et al. Depression among people with epilepsy in Northwest Ethiopia: a cross-sectional institution based study. BMC Res Notes. 2015;8:585.
   PubMedGoogle Scholar
• Spector S, Cull C, Goldstein LH. Seizure precipitants and perceived self-control of seizures in adults with poorly-controlled epilepsy. Epilepsy Res. 2000 Feb;38(2–3):207–216.
   PubMed Web of Science ®Google Scholar
• Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia. 1999;40(Suppl 10):S21–47.
   PubMed Web of Science ®Google Scholar
• Dimitriadis K, Pfefferkorn T, Noachtar S. Severe depression as the sole symptom of affective focal status epilepticus. BMJ Case Rep. 2014 May; pii: bcr2013201149. doi:10.1136/bcr-2013-201149.
   Google Scholar
• Mula M. Epilepsy-induced behavioral changes during the ictal phase. Epilepsy Behav. 2014 Jan;30:14–16.
   PubMed Web of Science ®Google Scholar
• Kanner AM, Soto A, Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology. 2004 Mar 9;62(5):708–713.
   PubMed Web of Science ®Google Scholar
• Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol. 1986 Aug;43:766–770.
   PubMed Web of Science ®Google Scholar
• Mori Y, Kanemoto K, Onuma T, et al. Anger is a distinctive feature of epilepsy patients with depression. Tohoku J Exp Med. 2014;232:123–128.
   PubMed Web of Science ®Google Scholar
• Robertson MM, Trimble MR, Townsend HR. Phenomenology of depression in epilepsy. Epilepsia. 1987 Jul–Aug;28:364–372.
   PubMed Web of Science ®Google Scholar
• Wiglusz MS, Landowski J, Michalak L, et al. Symptom frequency characteristics of the Hamilton depression rating scale of major depressive disorder in epilepsy. Psychiatr Danub. 2015 Sep;27(Suppl 1):S227–30.
   Google Scholar
• Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav. 2000 Apr;1:100–105.
   PubMed Web of Science ®Google Scholar
• Mula M. The interictal dysphoric disorder of epilepsy: a still open debate. Curr Neurol Neurosci Rep. 2013 Jun;13:355.
   PubMed Web of Science ®Google Scholar
• Mula M, Jauch R, Cavanna A, et al. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia. 2008;49:650–656.
   PubMed Web of Science ®Google Scholar
• Amiri M, Hansen CP. The interictal dysphoric disorder in patients with epilepsy: A doubtful disorder lacking diagnostic tools. Seizure. 2015 Jan;24:70–76.
   PubMed Web of Science ®Google Scholar
• Vaaler AE, Morken G, Iversen VC, et al. Acute unstable depressive syndrome (AUDS) is associated more frequently with epilepsy than major depression. BMC Neurol. 2010;10:67.
   PubMed Web of Science ®Google Scholar
• Pineda EA, Hensler JG, Sankar R, et al. Interleukin-1beta causes fluoxetine resistance in an animal model of epilepsy-associated depression. Neurotherapeutics. 2012;9:477–485.
   PubMed Web of Science ®Google Scholar
• Mazarati AM, Shin D, Kwon YS, et al. Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol Dis. 2009;34:457–461.
   PubMed Web of Science ®Google Scholar
• Pineda EA, Hensler JG, Sankar R, et al. Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression. Neuropsychopharmacology. 2011;36:1305–1316.
   PubMed Web of Science ®Google Scholar
• Pineda E, Shin D, Sankar R, et al. Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms. Epilepsia. 2010 Jul;51(Suppl 3):110–114.
   PubMed Web of Science ®Google Scholar
• Hasler G, Bonwetsch R, Giovacchini G, et al. 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry. 2007 Dec 1;62:1258–1264.
   PubMed Web of Science ®Google Scholar
• Rocha L, Alonso-Vanegas M, Villeda-Hernandez J, et al. Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy. Neurobiol Dis. 2012;45:499–507.
   PubMed Web of Science ®Google Scholar
• Peng WF, Ding J, Mao LY, et al. Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy. Epilepsy Behav. 2013;29:144–149.
   PubMed Web of Science ®Google Scholar
• Gruenbaum SE, Wang H, Zaveri HP, et al. Inhibition of glutamine synthetase in the central nucleus of the amygdala induces anhedonic behavior and recurrent seizures in a rat model of mesial temporal lobe epilepsy. Epilepsy Behav. 2015;51:96–103.
   PubMed Web of Science ®Google Scholar
• Toro CT, Hallak JE, Dunham JS, et al. The NR1 N-methyl-D-aspartate subunit and brain-derived neurotrophic factor in temporal lobe epilepsy hippocampus: a comparison of patients with and without coexisting psychiatric symptoms. Epilepsia. 2007;48:2352–2356.
   PubMed Web of Science ®Google Scholar
• Rocha L, Alonso-Vanegas M, Martinez-Juarez IE, et al. GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors. Front Cell Neurosci. 2014;8:442.
   PubMed Web of Science ®Google Scholar
• Jobe PC, Laird HE II, Ko KH, et al. Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat. Epilepsia. 1982;23:359–366.
   PubMed Web of Science ®Google Scholar
• Butler T, Blackmon K, McDonald CR, et al. Cortical thickness abnormalities associated with depressive symptoms in temporal lobe epilepsy. Epilepsy Behav. 2012;23:64–67.
   PubMed Web of Science ®Google Scholar
• Briellmann RS, Hopwood MJ, Jackson GD. Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates. J Neurol Neurosurg Psychiatry. 2007 Nov;78:1226–1230.
   PubMed Web of Science ®Google Scholar
• Hecimovic H, Santos J, Price JL, et al. Severe hippocampal atrophy is not associated with depression in temporal lobe epilepsy. Epilepsy Behav. 2014;34:9–14.
   PubMed Web of Science ®Google Scholar
• Chen S, Wu X, Lui S, et al. Resting-state fMRI study of treatment-naive temporal lobe epilepsy patients with depressive symptoms. Neuroimage. 2012;60:299–304.
   PubMed Web of Science ®Google Scholar
• Kemmotsu N, Kucukboyaci NE, Leyden KM, et al. Frontolimbic brain networks predict depressive symptoms in temporal lobe epilepsy. Epilepsy Res. 2014;108:1554–1563.
   PubMed Web of Science ®Google Scholar
• de Lemos Zingano B, Guarnieri R, Diaz AP, et al. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy. Epilepsy Behav. 2015;50:61–66.
   PubMed Web of Science ®Google Scholar
• Fiest KM, Patten SB, Wiebe S, et al. Validating screening tools for depression in epilepsy. Epilepsia. 2014;55:1642–1650.
   PubMed Web of Science ®Google Scholar
• de Oliveira GN, Lessa JM, Goncalves AP, et al. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI). Epilepsy Behav. 2014;34:50–54.
   PubMed Web of Science ®Google Scholar
• Kerr MP, Mensah S, Besag F, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia. 2011;52:2133–2138.
   PubMed Web of Science ®Google Scholar
• Friedman DE, Kung DH, Laowattana S, et al. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure. 2009;18:429–433.
   PubMed Web of Science ®Google Scholar
• Fiest KM, Patten SB, Altura KC, et al. Patterns and frequency of the treatment of depression in persons with epilepsy. Epilepsy Behav. 2014;39:59–64.
   PubMed Web of Science ®Google Scholar
• Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 2008 Jul;13(Suppl 1):S1–29.
   PubMedGoogle Scholar
• Maguire MJ, Weston J, Singh J, et al. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2014 Dec;12:CD010682.
   Web of Science ®Google Scholar
• Spina E, Santoro V, D’Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther. 2008 Jul;30:1206–1227.
   PubMed Web of Science ®Google Scholar
• Ghosh C, Hossain M, Spriggs A, et al. Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study. Epilepsia. 2015 Mar;56:439–449.
   PubMed Web of Science ®Google Scholar
• Melani F, Rosati E, Chiocchetti B, et al. Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses? Epilepsy Behav. 2009;14:681–683.
   PubMed Web of Science ®Google Scholar
• Payandemehr B, Ghasemi M, Dehpour AR. Citalopram as a good candidate for treatment of depression in patients with epilepsy. Epilepsy Behav. 2015 Mar;44:96–97.
   PubMed Web of Science ®Google Scholar
• McKean J, Watts H, Mokszycki R. Breakthrough seizures after starting vilazodone for depression. Pharmacotherapy. 2015 Mar;35:e6–8.
   Google Scholar
• Ahern TH, Javors MA, Eagles DA, et al. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology. 2006;31:730–738.
   PubMed Web of Science ®Google Scholar
• Noe KH, Locke DE, Sirven JI. Treatment of depression in patients with epilepsy. Curr Treat Options Neurol. 2011 Aug;13:371–379.
   PubMed Web of Science ®Google Scholar
• Unholzer S, Haen E. Retrospective analysis of therapeutic drug monitoring data for treatment of bipolar disorder with lamotrigine. Pharmacopsychiatry. 2015 Sep;48:211–214.
   PubMed Web of Science ®Google Scholar
• Saito S, Shioda K, Nisijima K. Anger with murderous impulse induced by lamotrigine. Gen Hosp Psychiatry. 2014 Jul–Aug;36:451.e1-2.
   Web of Science ®Google Scholar
• Edwards KR, Sackellares JC, Vuong A, et al. Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav. 2001;2:28–36.
   PubMed Web of Science ®Google Scholar
• Denicoff KD, Meglathery SB, Post RM, et al. Efficacy of carbamazepine compared with other agents: a clinical practice survey. J Clin Psychiatry. 1994;55:70–76.
   PubMed Web of Science ®Google Scholar
• Goel RK, Gawande D, Lagunin A, et al. Revealing medicinal plants that are useful for the comprehensive management of epilepsy and associated comorbidities through in silico mining of their phytochemical diversity. Planta Med. 2015;81:495–506.
   PubMed Web of Science ®Google Scholar
• Peng WF, Wang X, Hong Z, et al. The anti-depression effect of Xylaria nigripes in patients with epilepsy: A multicenter randomized double-blind study. Seizure. 2015;29:26–33.
   PubMed Web of Science ®Google Scholar
• Gandy M, Sharpe L, Nicholson Perry K, et al. Cognitive behaviour therapy for depression in people with epilepsy: a systematic review. Epilepsia. 2013;54(10):1725–1734.
   PubMed Web of Science ®Google Scholar
• Orjuela-Rojas JM, Martinez-Juarez IE, Ruiz-Chow A, et al. Treatment of depression in patients with temporal lobe epilepsy: A pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors. Epilepsy Behav. 2015;51:176–181.
   PubMed Web of Science ®Google Scholar
• Nune G, DeGiorgio C, Heck C. Neuromodulation in the treatment of epilepsy. Curr Treat Options Neurol. 2015 Oct;17:375.
   PubMed Web of Science ®Google Scholar
• Hakimova H, Kim S, Chu K, et al. Ultrasound stimulation inhibits recurrent seizures and improves behavioral outcome in an experimental model of mesial temporal lobe epilepsy. Epilepsy Behav. 2015;49:26–32.
   PubMed Web of Science ®Google Scholar
• Sugiyama K, Nozaki T, Asakawa T, et al. The present indication and future of deep brain stimulation. Neurol Med Chir (Tokyo). 2015;55:416–421.
   PubMed Web of Science ®Google Scholar
• Hessen E, Lossius MI, Reinvang I, et al. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy. Epilepsy Behav. 2007;10:449–455.
   PubMed Web of Science ®Google Scholar